StockWatch
·

JENBURKT PHARMACEUTICALS LTD. Q3 FY25 Results

JENBURPHQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue36.8910.5%
Total Income38.4810.7%
Expenditure28.965.2%
PBT9.5124.0%
Net Profit6.5132.2%
OPM19.09%4.97pp
NPM16.91%5.38pp
EPS14.7532.2%
View full financials

Informational and educational content only. Not investment advice.